Arrhythmogenic Potential of Heterozygous TECRL Variants in Type 3 Catecholaminergic Polymorphic Ventricular Tachycardia

IF 7.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JACC. Clinical electrophysiology Pub Date : 2025-04-01 Epub Date: 2025-02-12 DOI:10.1016/j.jacep.2024.12.015
Alessandra Pia Porretta MD, PhD , Mathieu Le Bloa MD , Zahurul Alam Bhuiyan MD, PhD , Nicole Sekarski MD , Isis Atallah MD , Cédric Le Caignec MD, PhD , Fabrice Extramiana MD, PhD , Etienne Pruvot MD
{"title":"Arrhythmogenic Potential of Heterozygous TECRL Variants in Type 3 Catecholaminergic Polymorphic Ventricular Tachycardia","authors":"Alessandra Pia Porretta MD, PhD ,&nbsp;Mathieu Le Bloa MD ,&nbsp;Zahurul Alam Bhuiyan MD, PhD ,&nbsp;Nicole Sekarski MD ,&nbsp;Isis Atallah MD ,&nbsp;Cédric Le Caignec MD, PhD ,&nbsp;Fabrice Extramiana MD, PhD ,&nbsp;Etienne Pruvot MD","doi":"10.1016/j.jacep.2024.12.015","DOIUrl":null,"url":null,"abstract":"<div><div><em>TECRL</em> is the causative gene of an autosomal-recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT), the so-called type 3 CPVT. However, only 17 families have been reported worldwide and no case of symptomatic heterozygous carriers has been described. We report herein genotypes and clinical phenotypes of a family of European ancestry harboring a new <em>TECRL</em> pathogenic variant and, for the first time, a CPVT-like phenotype in a <em>TECRL</em> heterozygous variant carrier. Due to this novel evidence, clinicians should be aware that <em>TECRL</em> heterozygous variant carriers should undergo cardiac assessment and therapy introduction in case of a CPVT clinical diagnosis.</div></div>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":"11 4","pages":"Pages 818-822"},"PeriodicalIF":7.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Clinical electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405500X24010375","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

TECRL is the causative gene of an autosomal-recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT), the so-called type 3 CPVT. However, only 17 families have been reported worldwide and no case of symptomatic heterozygous carriers has been described. We report herein genotypes and clinical phenotypes of a family of European ancestry harboring a new TECRL pathogenic variant and, for the first time, a CPVT-like phenotype in a TECRL heterozygous variant carrier. Due to this novel evidence, clinicians should be aware that TECRL heterozygous variant carriers should undergo cardiac assessment and therapy introduction in case of a CPVT clinical diagnosis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
杂合型TECRL变异在3型儿茶酚胺能多态性室性心动过速中的致心律失常电位。
TECRL是常染色体隐性形式的儿茶酚胺能多态性室性心动过速(CPVT)的致病基因,即所谓的3型CPVT。然而,在世界范围内仅报道了17个家族,没有描述有症状的杂合子携带者。我们在此报告了一个欧洲血统家庭的基因型和临床表型,其中包含一个新的TECRL致病变异,并首次在TECRL杂合变异携带者中发现cpvt样表型。由于这一新的证据,临床医生应该意识到,在临床诊断为CPVT的情况下,TECRL杂合变异携带者应该进行心脏评估和治疗介绍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JACC. Clinical electrophysiology
JACC. Clinical electrophysiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
10.30
自引率
5.70%
发文量
250
期刊介绍: JACC: Clinical Electrophysiology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC). It encompasses all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. Submissions of original research and state-of-the-art reviews from cardiology, cardiovascular surgery, neurology, outcomes research, and related fields are encouraged. Experimental and preclinical work that directly relates to diagnostic or therapeutic interventions are also encouraged. In general, case reports will not be considered for publication.
期刊最新文献
Catheter Ablation for Supraventricular Tachyarrhythmias in Adults With Total Cavopulmonary Connection Fontan Palliation. Number of Pacing Stimuli for Attaining a Plateau Post-Pacing Interval for Diagnosing Re-Entrant Atrial Tachycardia. Premature Ventricular Complexes After Atrial Fibrillation Ablation: Impact of Extensive Ablation Strategies and Vein of Marshall Ethanol. Vein of Marshall Ethanol Infusion in Atrial Fibrillation. Left Atrial Appendage Occlusion in Patients With Hereditary Hemorrhagic Telangiectasia and Atrial Fibrillation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1